COVID-19 long-haulers—even those who experienced mild cases—are at significantly increased risk for substantial declines in kidney function, such as organ damage and chronic and end-stage kidney disease (ESKD), according to a study today in the Journal of the American Society of Nephrology.
WHO releases new compendium of innovative health technologies for COVID-19 and other priority diseases.
A recent study in Antimicrobial Agents and Chemotherapy compared combination therapy consisting of a ß-lactam plus an aminoglycoside with ß-lactam monotherapy in hematological neutropenic patients with gram-negative bloodstream infections.
Nakshathra Medi Science Pvt Ltd is a super specialty pharmaceutical company with a clear vision and aim to build up a strong presence in Critical Care, Intensive care Neurology, Nephrology, Urology and Nutraceuticals. We will Establish the organisation in ethical and scientific path, with its corporate office based in Chennai. NMSPL is dedicated in serving quality medicines for a healthier lifestyle.